{"database": "lobbying", "table": "lobbying_activities", "rows": [[1257896, "6dc668bf-df49-4fdf-a1fd-fbcccb1db8c3", "Q2", "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 1466, "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 2012, "second_quarter", "MED", "AACC contacted House leaders to support provisions Sections 721 and 203(f) of H.R.5651, Food and Drug Administration Reform Act of 2012, which sought to streamline the FDA de novo medical device review process and give the HHS Secretary authority to waive FDA medical device user fees in the interest of public health.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2012-07-03T10:56:49.673000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1257896"], "units": {}, "query_ms": 3.6288860137574375, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}